{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T08:45:21Z","timestamp":1771922721367,"version":"3.50.1"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Inflammatory biomarkers and immune cell function may provide prognostic value beyond traditional severity scores in hospitalized cirrhosis patients. We aimed to characterize inflammatory and immune profiles to determine their predictive value for ICU admission, infection, and long-term mortality, and to develop novel scoring systems.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>This retrospective observational cohort study enrolled 78 hospitalized cirrhosis patients. Comprehensive inflammatory profiling included 12 cytokines (multiplex immunoassay), flow cytometry immune markers, and acute phase reactants (e.g., procalcitonin). Outcome measures included ICU admission, infection, and death within 12\u201324\u202fmonths. Multivariable logistic regression was used to identify independent predictors and develop three outcome-specific scoring systems.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The cohort had a mean MELD3 of 25.14; 38.5% required ICU admission, and 12\u201324-month mortality was 43.6%. Independent predictors for infection were procalcitonin (\u22650.40\u202fng\/mL), IL-6 (\u226584\u202fpg.\/mL), and creatinine (\u22651.35\u202fmg\/dL) (AUC 0.74). ICU admission was predicted by hepatic encephalopathy, variceal bleeding, procalcitonin (\u22650.40\u202fng\/mL), and IL-6 (\u226553.69\u202fpg.\/mL) (AUC 0.82). Long-term mortality was predicted by ICU admission, hemoglobin (\u226411.5\u202fg\/dL), EGF (\u22642.9\u202fpg.\/mL), and absolute nucleated cell count (\u22643,600\/\u03bcL) (AUC 0.821).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Biomarkers reflecting systemic inflammation (IL-6, procalcitonin), immune paresis (low nucleated cell count), and failed regenerative capacity (low EGF) strongly predicted adverse outcomes. Integrating these markers into the proposed \u2018Sick Cirrhosis Patient Scores\u2019 may improve risk stratification, but these models require rigorous external validation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1736956","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:41:05Z","timestamp":1768977665000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond traditional\u2014the sick cirrhosis patient scores integrating cytokine and immune profiling for precision prognosis in hospitalized cirrhosis patients may help predict infection, ICU admission and long-term death post hospitalization"],"prefix":"10.3389","volume":"13","author":[{"given":"Cyriac Abby","family":"Philips","sequence":"first","affiliation":[{"name":"Department of Clinical and Translational Hepatology, The Liver Institute, Center of Excellence in Gastrointestinal Sciences, Rajagiri Hospital","place":["Kochi, Kerala, India"]},{"name":"Clinical Research Division, The Liver Institute, Center of Excellence in Gastrointestinal Sciences, Rajagiri Hospital","place":["Kochi, Kerala, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tharun Tom","family":"Oommen","sequence":"additional","affiliation":[{"name":"Department of Clinical and Translational Hepatology, The Liver Institute, Center of Excellence in Gastrointestinal Sciences, Rajagiri Hospital","place":["Kochi, Kerala, India"]},{"name":"Department of Gastroenterology and Advanced GI Endoscopy, Center of Excellence in Gastrointestinal Sciences, Rajagiri Hospital","place":["Kochi, Kerala, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arif Hussain","family":"Theruvath","sequence":"additional","affiliation":[{"name":"Clinical Research Division, The Liver Institute, Center of Excellence in Gastrointestinal Sciences, Rajagiri Hospital","place":["Kochi, Kerala, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aryalakshmi","family":"Sreemohan","sequence":"additional","affiliation":[{"name":"Clinical Research Division, The Liver Institute, Center of Excellence in Gastrointestinal Sciences, Rajagiri Hospital","place":["Kochi, Kerala, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambily","family":"Baby","sequence":"additional","affiliation":[{"name":"Clinical Research Division, The Liver Institute, Center of Excellence in Gastrointestinal Sciences, Rajagiri Hospital","place":["Kochi, Kerala, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ansu Abu","family":"Alex","sequence":"additional","affiliation":[{"name":"Department of Advanced Flow Cytometry Immunophenotyping Facility, Rajagiri Hospital","place":["Kochi, Kerala, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunitha","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Services, Rajagiri Hospital","place":["Kochi, Kerala, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunitha Mary","family":"John","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Rajagiri Hospital","place":["Kochi, Kerala, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rizwan","family":"Ahamed","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Advanced GI Endoscopy, Center of Excellence in Gastrointestinal Sciences, Rajagiri Hospital","place":["Kochi, Kerala, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajit","family":"Tharakan","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Advanced GI Endoscopy, Center of Excellence in Gastrointestinal Sciences, Rajagiri Hospital","place":["Kochi, Kerala, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Augustine","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Advanced GI Endoscopy, Center of Excellence in Gastrointestinal Sciences, Rajagiri Hospital","place":["Kochi, Kerala, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41575-023-00759-2","article-title":"Global epidemiology of cirrhosis \u2013 aetiology, trends and predictions","volume":"20","author":"Huang","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1097\/HEP.0000000000001243","article-title":"Prevalence and predictors of cirrhosis and portal hypertension in the United States","volume":"82","author":"Younossi","year":"2025","journal-title":"Hepatology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1111\/apt.18016","article-title":"Review article: evaluation and care of the critically ill patient with cirrhosis","volume":"59","author":"Kosuta","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e0762","DOI":"10.1097\/HC9.0000000000000762","article-title":"Long-term outcomes after ICU admission in critically ill patients with liver cirrhosis: an Australian state-wide cohort study","volume":"9","author":"Con","year":"2025","journal-title":"Hepatol Commun"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jamcollsurg.2016.11.005","article-title":"Predictors of mortality in the critically ill cirrhotic patient: is the model for end-stage liver disease enough?","volume":"224","author":"Annamalai","year":"2017","journal-title":"J Am Coll Surg"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1055\/a-2464-9543","article-title":"Advancements in MELD score and its impact on hepatology","volume":"45","author":"Hudson","year":"2025","journal-title":"Semin Liver Dis"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.14309\/ajg.0000000000003056","article-title":"Clinical implications of inflammation in patients with cirrhosis","volume":"120","author":"Kronsten","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jhep.2020.11.048","article-title":"The systemic inflammation hypothesis: towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis","volume":"74","author":"Arroyo","year":"2021","journal-title":"J Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2020.06.013","article-title":"The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology","volume":"73","author":"Trebicka","year":"2020","journal-title":"J Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1268102","DOI":"10.3389\/fmed.2023.1268102","article-title":"Prognostic assessment of liver cirrhosis and its complications: current concepts and future perspectives","volume":"10","author":"G\u00fclcicegi","year":"2023","journal-title":"Front Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jhep.2024.06.016","article-title":"Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation","volume":"81","author":"Taru","year":"2024","journal-title":"J Hepatol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"20039","DOI":"10.1038\/s41598-023-47384-2","article-title":"Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry study","volume":"13","author":"Mynster Kronborg","year":"2023","journal-title":"Sci Rep"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"156347","DOI":"10.1016\/j.cyto.2023.156347","article-title":"Role of inflammasomes and cytokines in immune dysfunction of liver cirrhosis","volume":"170","author":"Pratim Das","year":"2023","journal-title":"Cytokine"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/hepr.14175","article-title":"Serum pro-inflammatory cytokine interleukin-6 level is predictive of further decompensation and mortality in liver cirrhosis","volume":"55","author":"Ikeda","year":"2025","journal-title":"Hepatol Res"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1471-230X-9-72","article-title":"Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation","volume":"9","author":"Gotthardt","year":"2009","journal-title":"BMC Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e2877","DOI":"10.1097\/MD.0000000000002877","article-title":"Child-Pugh versus MELD score for the assessment of prognosis in liver cirrhosis: a systematic review and meta-analysis of observational studies","volume":"95","author":"Peng","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"22113","DOI":"10.1038\/s41598-023-48819-6","article-title":"MELD-Na score may underestimate disease severity and risk of death in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"13","author":"Yardeni","year":"2023","journal-title":"Sci Rep"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"876","DOI":"10.4103\/aam.aam_271_24","article-title":"Assessment of Interleukin-6 levels in patients with liver cirrhosis and its correlation with disease severity and mortality","volume":"24","author":"Sharma","year":"2025","journal-title":"Ann Afr Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.dld.2023.10.004","article-title":"Prognostic value of procalcitonin in patients with cirrhosis hospitalized for acute infection","volume":"56","author":"Girardi","year":"2024","journal-title":"Dig Liver Dis"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e5127","DOI":"10.1097\/MD.0000000000005127","article-title":"Serum interleukin-6 in the diagnosis of bacterial infection in cirrhotic patients: a meta-analysis","volume":"95","author":"Wu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cyto.2015.10.006","article-title":"Immune dysfunction in cirrhosis: distinct cytokines phenotypes according to cirrhosis severity","volume":"77","author":"Dirchwolf","year":"2016","journal-title":"Cytokine"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.jcrc.2015.03.031","article-title":"Interleukin-6 as an early diagnostic marker for bacterial sepsis in patients with liver cirrhosis","volume":"30","author":"Lin","year":"2015","journal-title":"J Crit Care"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"5582","DOI":"10.3390\/jcm13185582","article-title":"Liver cirrhosis: the immunocompromised state","volume":"13","author":"Rodr\u00edguez-Negrete","year":"2024","journal-title":"J Clin Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/ijms17010030","article-title":"EGFR Signaling in liver diseases","volume":"17","author":"Komposch","year":"2015","journal-title":"Int J Mol Sci"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.3390\/cancers3022444","article-title":"Epidermal growth factor receptor (EGFR) crosstalks in liver cancer","volume":"3","author":"Berasain","year":"2011","journal-title":"Cancers"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"777","DOI":"10.12998\/wjcc.v10.i3.777","article-title":"Anemia in cirrhosis: an underestimated entity","volume":"10","author":"Manrai","year":"2022","journal-title":"World J Clin Cases"},{"key":"ref27","first-page":"103","article-title":"Anemia en pacientes internados con cirrosis: prevalencia, significaci\u00f3n cl\u00ednica y factores predictivos [Anemia in hospitalized patients with cirrhosis: prevalence, clinical relevance and predictive factors]","volume":"39","author":"Mathurin","year":"2009","journal-title":"Acta Gastroenterol Latinoam"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1736956\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:40:12Z","timestamp":1771918812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1736956\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":27,"alternative-id":["10.3389\/fmed.2026.1736956"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1736956","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"article-number":"1736956"}}